UroGen Pharma Ltd.の営業利益成長率推移

損益計算書

	2017/12/31	2018/12/31	2019/12/31	2020/12/31	2021/12/31	2022/12/31
Revenue	8	1	0	12	48	64
Cost of revenue	1	2		1	5	8
Gross profit	8	-1	0	11	43	57
Research and development expenses
Selling, general and administrative expenses
Operating loss
Financing on prepaid forward obligation
Interest expense on long-term debt
Interest and other income, net
Loss before income taxes
Income tax expense
Net Loss
Net loss
Unrealized (loss) on investments
Comprehensive Loss
Net loss per ordinary share - basic and diluted (in dollars per share)